A Scientific Statement From the AHA on CV Risk in Nonalcoholic Fatty Liver Disease
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
For older adults with aortic stenosis (AS), calcium supplementation, with or without vitamin D, is associated with increased mortality and aortic valve replacement (AVR).
The American Society for Preventive Cardiology issued a clinical practice statement regarding risk assessment for atherosclerotic cardiovascular disease.
Investigators examined the independent and joint association of lipoprotein(a) and coronary artery calcium with risk for atherosclerotic cardiovascular disease.
Researchers assessed the effect of a new risk prediction tool on clinical outcomes and behavioral changes in patients with ASCVD.
A study was conducted to examine the relationship between multiple patient factors and use of glucagon-like peptide-1 receptor agonists in patients with ASCVD and T2D.
Investigators compared the long-term effects of febuxostat on arterial stiffness and atherosclerosis in patients with hyperuricemia and gout.
Researchers conducted a meta-analysis to determine real-world prevalence of statin intolerance.
A study was conducted to determine the relationship between breast arterial calcification and risk for atherosclerotic cardiovascular disease.
Investigators sought to determine whether cTnI and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) were associated with carotid plaque burden and CV events independent of the Framingham Risk Score (FRS).